Featured Research

from universities, journals, and other organizations

Patients Treated Successfully For Hodgkin's Disease Are At 9 Times The Risk For Developing Second Cancers

Date:
May 6, 1999
Source:
University At Buffalo
Summary:
Persons treated for Hodgkin's disease in childhood are at high risk for developing a second malignancy and should be monitored closely by their physicians throughout their lifetime, researchers at the University at Buffalo and Roswell Park Cancer Institute (RPCI) have shown.

UB study shows risk of thyroid cancer 164 times higher for men

Related Articles


SAN FRANCISCO -- Persons treated for Hodgkin's disease in childhood are at high risk for developing a second malignancy and should be monitored closely by their physicians throughout their lifetime, researchers at the University at Buffalo and Roswell Park Cancer Institute (RPCI) have shown.

Results of two studies on this issue were presented here today (May 2, 1999) at the annual meeting of the Society for Pediatric Research.

The findings showed that persons treated for Hodgkin's Disease as children were at nine times the risk of developing a second cancer, with risks of developing certain types of cancer much higher than that, compared to patients without Hodgkin's disease.

The risk of developing thyroid cancer in males was especially high -- 164 times that of controls.

"These are big relative risks," said Daniel M. Green, M.D., UB professor of pediatrics, a specialist in pediatric oncology at RPCI and senior researcher on the studies. "These studies should alert physicians to the need for careful and continuing screening at a much earlier age than the American Cancer Society recommends for the population at large."

The studies involved 182 patients treated at RPCI for Hodgkin's disease between 1960 and 1989. All were less than 20 years old when their disease was diagnosed. By the time they were 30, 27 percent of the patients had developed at least one second cancer, excluding skin cancer. A second study reported on incidence of skin cancer only.

The relative risks for developing one of the more prevalent second cancers were found to be nine times greater than for persons without Hodgkin's disease in both males and females. The relative risk for thyroid cancer was 164 times greater for males and 39 times greater for females; for breast cancer, eight times greater for females; for non-Hodgkin's lymphoma, 15 times greater for males and 23 times greater for females; and leukemia, 19 times greater for males and 25 times greater for females.

"With higher survival rates for Hodgkin's disease, we are going to see more second cancers down the road," said Julie A. Reynolds, M.D., pediatric resident at The Children's Hospital of Buffalo and first author on the study. "We need to look at the data to see the influence of various treatments, and to educate the patient about the need for screening." No one treatment was found to have a significant effect on second-cancer risk.

In the study on basal cell carcinoma alone, headed by Green, findings showed that the most important variable was combined treatment with radiation and chemotherapy.

Of patients who received radiation therapy alone, 3 percent developed skin cancer by the age of 14, and 5.6 percent of patients who received combined therapy developed skin cancer by the time they were 20.

"Children and adolescents who have been treated successfully for Hodgkin's disease should be told about their risk of developing non-melanoma skin cancer, and should receive thorough examinations of the skin and be well-schooled regarding safe sun exposure," Green said.

Additional researchers on the studies were Maurice P. Barcos, M.D., Ph.D., and Michael Zevon, Ph.D., both of UB and RPCI; and R. Jeffrey Lee, MD, and Brenda C. Hall, pediatric nurse practitioner in oncology, both of RPCI.


Story Source:

The above story is based on materials provided by University At Buffalo. Note: Materials may be edited for content and length.


Cite This Page:

University At Buffalo. "Patients Treated Successfully For Hodgkin's Disease Are At 9 Times The Risk For Developing Second Cancers." ScienceDaily. ScienceDaily, 6 May 1999. <www.sciencedaily.com/releases/1999/05/990506065945.htm>.
University At Buffalo. (1999, May 6). Patients Treated Successfully For Hodgkin's Disease Are At 9 Times The Risk For Developing Second Cancers. ScienceDaily. Retrieved March 6, 2015 from www.sciencedaily.com/releases/1999/05/990506065945.htm
University At Buffalo. "Patients Treated Successfully For Hodgkin's Disease Are At 9 Times The Risk For Developing Second Cancers." ScienceDaily. www.sciencedaily.com/releases/1999/05/990506065945.htm (accessed March 6, 2015).

Share This


More From ScienceDaily



More Health & Medicine News

Friday, March 6, 2015

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Bupa Eyes India Healthcare Opportunities

Bupa Eyes India Healthcare Opportunities

Reuters - Business Video Online (Mar. 5, 2015) Bupa is hoping to expand in India&apos;s fast-growing health insurance market, once a rule change on foreign investment is implemented. The British private healthcare group&apos;s CEO tells Grace Pascoe why it&apos;s so keen on the new opportunity. Video provided by Reuters
Powered by NewsLook.com
Doctor in Your Pocket Is Getting Smarter

Doctor in Your Pocket Is Getting Smarter

Reuters - Business Video Online (Mar. 5, 2015) Mobile apps are turning smartphones into a personal doctors, with users able to measure heart rate, blood pressure and even blood sugar. But will it change our behaviour? Ivor Bennett reports from the Mobile World Congress in Barcelona. Video provided by Reuters
Powered by NewsLook.com
AbbVie Inks $21B Deal To Buy Cancer Drugmaker Pharmacyclics

AbbVie Inks $21B Deal To Buy Cancer Drugmaker Pharmacyclics

Newsy (Mar. 5, 2015) AbbVie announced Wednesday it will buy cancer drugmaker Pharmacyclics in a $21 billion deal. Video provided by Newsy
Powered by NewsLook.com
Toddlers Drinking Coffee? Why You Shouldn't Share Your Joe

Toddlers Drinking Coffee? Why You Shouldn't Share Your Joe

Newsy (Mar. 5, 2015) A survey of Boston mothers and toddlers found that 15 percent of two-year-olds drink coffee and 2.5 percent of 1-year-olds. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins